Delisting riskPopularity #3,471
GUTS · NASDAQ · Biotechnology

Fractyl Health (GUTS)

Develops clinical-stage therapies for obesity and type 2 diabetes through the gut and pancreas.

$0.4889
vs last close−0.06 (−11.59%)